BSE filing, BSE: 544310. Summary written from the filing by ALFA Finder's alert engine.
Yash Highvoltage Ltd: key numbers
- Share price
- ₹1,248.35
- Market cap
- ₹3,732 Cr
- Revenue (annual)
- ₹235.2 Cr
- Net profit (annual)
- ₹37.32 Cr
- P/E (TTM)
- 100.0×Sector 52.2×
- Promoter holding
- 53.79%
- FII holding
- 2.26%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Yash Highvoltage Ltd
All →Yash Highvoltage Earnings Call Transcript: Key Takeaways
Yash Highvoltage delivers explosive 95% YoY revenue growth, driven by domestic infrastructure demand and pricing power.
- Call
- Guides 414% growth
Yash Highvoltage Other Announcement
Yash Highvoltage Limited submitted its quarterly Statement of Deviation or Variation in utilization of funds raised through a preferential issue as required under SEBI regulations.
Yash Highvoltage Results Update
Yash Highvoltage's H1 FY27 revenue grew 95% YoY to ₹194.5 crore, with EBITDA rising to ₹54.7 crore and PAT to ₹36.2 crore.
Yash Highvoltage Investor Presentation: Key Takeaways
Yash Highvoltage reported strong H1FY27 performance with revenue growth of 95% YoY. Management highlights international expansion, specifically in the US, and upcoming commissioning of a new greenfield facility for backward integration.
- Call
- Guides 300% growth
Yash Highvoltage H1 FY27 Results: Net Profit ₹36.4 Cr, Up 165.7% QoQ
Yash Highvoltage Ltd reported revenue from operations of ₹194.5 Cr and net profit of ₹36.4 Cr for H1 FY27.
- Key figure
- Net profit ₹36.4 Cr
Yash Highvoltage Partnership
Yash Highvoltage's subsidiary, YASH HV USA INC., appointed EHV Solutions LLC as a sales representative for 3 years to expand US market presence.
- Execution
- 36 months
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date